Complicated Intra-Abdominal Infections, cIAIs

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Complicated Intra-Abdominal Infections, cIAIs trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07268560

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Why This Study is Needed Some bacterial infections have become resistant to common antibiotics, making them very difficult to treat. This is a growing and serio…

China100 participantsStarted 2025-12-25

Treatment: Aztreonam-Avibactam

All recent trials (4 shown)

CompletedNot Applicable

NCT05549076

Hellenic Registry for cIAIs (HERCO-II)

Complicated Intra-Abdominal Infections (cIAIs) represent an emergent surgical situation which lead to important non trauma-related mortality in several Emergenc…

Greece300 participantsStarted 2022-10-01

CompletedPhase 2

NCT02655419

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Determine the PK and safety and tolerability of aztreonam-avibactam (ATM-AVI) in the treatment of hospitalized adults with cIAI

France, Germany, Spain40 participantsStarted 2016-05-19

Treatment: ATM-AVI, Metronidazole

Complicated Intra-Abdominal Infections, cIAIs

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

All recent trials (4 shown)

Hellenic Registry for cIAIs (HERCO-II)

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

All recent trials (4 shown)

Hellenic Registry for cIAIs (HERCO-II)

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years O…